Literature DB >> 26734632

Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition).

Jun Guo1, Shukui Qin1, Jun Liang1, Tongyu Lin1, Lu Si1, Xiaohong Chen1, Zhihong Chi1, Chuanliang Cui1, Nan Du1, Yun Fan1, Kangsheng Gu1, Fang Li1, Junling Li1, Yongheng Li1, Houjie Liang1, Jiwei Liu1, Man Lu1, Aiping Lu1, Kejun Nan1, Xiaohui Niu1, Hongming Pan1, Guoxin Ren1, Xiubao Ren1, Yongqian Shu1, Xin Song1, Min Tao1, Baocheng Wang1, Wenbin Wei1, Di Wu1, Lingying Wu1, Aiwen Wu1, Xiaolin Xu1, Junyi Zhang1, Xiaoshi Zhang1, Yiping Zhang1, Huiyan Zhu1.   

Abstract

Entities:  

Year:  2015        PMID： 26734632      PMCID： PMC4690993          DOI： 10.3978/j.issn.2305-5839.2015.12.23

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  215 in total

1.  Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation.

Authors:  Daniel T Chang; Robert J Amdur; Christopher G Morris; William M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-09-12       Impact factor: 7.038

2.  Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma.

Authors:  Ravi D Rao; Shernan G Holtan; James N Ingle; Gary A Croghan; Lisa A Kottschade; Edward T Creagan; Judith S Kaur; Henry C Pitot; Svetomir N Markovic
Journal:  Cancer       Date:  2006-01-15       Impact factor: 6.860

3.  Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma.

Authors:  Rebecca P Petersen; Steven I Hanish; John C Haney; Charles C Miller; William R Burfeind; Douglas S Tyler; Hilliard F Seigler; Walter Wolfe; Thomas A D'Amico; David H Harpole
Journal:  J Thorac Cardiovasc Surg       Date:  2007-01       Impact factor: 5.209

Review 4.  Treatment and outcomes of anorectal melanoma.

Authors:  Anna Heeney; Jurgen Mulsow; John M P Hyland
Journal:  Surgeon       Date:  2010-08-19       Impact factor: 2.392

5.  Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis.

Authors:  Yan Xing; Yulia Bronstein; Merrick I Ross; Robert L Askew; Jeffrey E Lee; Jeffrey E Gershenwald; Richard Royal; Janice N Cormier
Journal:  J Natl Cancer Inst       Date:  2010-11-16       Impact factor: 13.506

6.  Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma: multicenter, retrospective analysis in Asia.

Authors:  Jun Ho Yi; Seong Yoon Yi; Hye Ran Lee; Soon Il Lee; Do Hyoung Lim; Jung Han Kim; Keon Woo Park; Jeeyun Lee
Journal:  Melanoma Res       Date:  2011-06       Impact factor: 3.599

Review 7.  Role of sentinel lymph node biopsy in patients with thin melanoma.

Authors:  Robert H I Andtbacka; Jeffrey E Gershenwald
Journal:  J Natl Compr Canc Netw       Date:  2009-03       Impact factor: 11.908

8.  Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2.

Authors:  S A Rosenberg; J C Yang; S L Topalian; D J Schwartzentruber; J S Weber; D R Parkinson; C A Seipp; J H Einhorn; D E White
Journal:  JAMA       Date:  1994 Mar 23-30       Impact factor: 56.272

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

Review 10.  Systematic review of medical treatment in melanoma: current status and future prospects.

Authors:  Claus Garbe; Thomas K Eigentler; Ulrich Keilholz; Axel Hauschild; John M Kirkwood
Journal:  Oncologist       Date:  2011-01-06
View more
  24 in total

Review 1.  Pivotal MicroRNAs in Melanoma: A Mini-Review.

Authors:  Zhenjun Deng; Jingang Hao; Dongyun Lei; Yongjing He; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

2.  Adjuvant pembrolizumab versus high-dose interferon α-2b for Chinese patients with resected stage III melanoma: a retrospective cohort study.

Authors:  Tao Li; Dong-Dong Jia; Li-Song Teng
Journal:  Invest New Drugs       Date:  2020-02-18       Impact factor: 3.850

3.  LncRNA H19 promotes proliferation and invasion in A375 human melanoma cell line.

Authors:  Xiaoling Zhu; Wei Li; Qinggang Meng
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

4.  Percutaneous contrast-enhanced ultrasound for localization and qualitative diagnosis of sentinel lymph nodes in cutaneous malignant melanoma of lower extremities: a preliminary study.

Authors:  Rui-Qian Guo; Xi Xiang; Li-Yun Wang; Bi-Hui Zhu; Song-Ya Huang; Xin-Yi Tang; Jun-Jie Chen; Li Qiu
Journal:  Quant Imaging Med Surg       Date:  2022-01

5.  Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.

Authors:  Bo Chen; Donghong Sun; Xiuni Qin; Xing-Hua Gao
Journal:  Invest New Drugs       Date:  2021-01-26       Impact factor: 3.850

6.  Effect of MUC16 mutations on tumor mutation burden and its potential prognostic significance for cutaneous melanoma.

Authors:  Zi Wang; Huimin Hou; Haomin Zhang; Xingwu Duan; Lingling Li; Lingfeng Meng
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

Review 7.  Progressive visual disturbance and enlarging prolactinoma caused by melanoma metastasis: A case report and literature review.

Authors:  Chuanwei Yang; Ling Liu; Xiaoqiang Lan; Shiqiang Zhang; Xinyu Li; Bo Zhang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

8.  Cost-Effectiveness Analysis of Dabrafenib Plus Trametinib and Vemurafenib as First-Line Treatment in Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma in China.

Authors:  Tianfu Gao; Jia Liu; Jing Wu
Journal:  Int J Environ Res Public Health       Date:  2021-06-08       Impact factor: 3.390

9.  miR-128 enhances dendritic cell-mediated anti-tumor immunity via targeting of p38.

Authors:  Xue Liang; Wenfeng Shangguan; Miaomiao Zhang; Shiyue Mei; Liyang Wang; Rongcun Yang
Journal:  Mol Med Rep       Date:  2017-06-07       Impact factor: 2.952

Review 10.  Brain metastasis in a patient with melanoma receiving Pembrolizumab therapy: A case report and review of the literature.

Authors:  Jin-Cheng Song; Xiao-Lei Ding; Xiu-Hua Sun; Mohammed Safi; Juan Tian
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.